These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4967489)

  • 1. Influence of five anti-cancer drugs on the induction and growth of experimental mammary cancers: comparison with ovariectomy.
    Rees ED; Ross A
    Cancer; 1968 Jun; 21(6):1029-41. PubMed ID: 4967489
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine and cytostatic treatment of experimental mammary cancer.
    Fiebig HH; Schmähl D
    Recent Results Cancer Res; 1980; 71():80-95. PubMed ID: 6768114
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic chemotherapy for carcinoma of the cervix.
    Smith JP; Rutledge F; Burns BC; Soffar S
    Am J Obstet Gynecol; 1967 Mar; 97(6):800-7. PubMed ID: 4960089
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental toxicologic and therapeutic studies on the activity of the CMF(cyclophosphamide-methotrexate-5-fluorouracil) scheme versus the VMF(vincristine-methotrexate-5-fluorouracil) scheme].
    Berger MR; Habs M; Schmähl D
    Arch Geschwulstforsch; 1984; 54(4):263-78. PubMed ID: 6548622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Thymus in Experimental Mammary Carcinogenesis and Polychemotherapy.
    Kazakov OV; Kabakov AV; Ishchenko IY; Poveshchenko AF; Raiter TV; Strunkin DN; Michurina SV; Konenkov VI
    Bull Exp Biol Med; 2017 Feb; 162(4):479-482. PubMed ID: 28243914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 7. [Place of chemotherapy in the treatment of primary bronchial cancers].
    Spina G; Ingrao F; Tansini G
    Bronches; 1971; 21(2):157-75. PubMed ID: 5126167
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth inhibition of rat mammary carcinoma induced by cis-platinum diamminodichloride-II.
    Welsch CW
    J Natl Cancer Inst; 1971 Nov; 47(5):1071-8. PubMed ID: 5123334
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy of 3-methylcholanthrene-induced mammary carcinoma in rats: effect of chemotherapy, ovariectomy, and food restriction.
    Gropper L; Shimkin MB
    Cancer Res; 1967 Jan; 27(1):26-32. PubMed ID: 6071371
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapeutic response of 3-methylcholanthrene-induced mammary carcinoma in Wistar rats to 51 agents.
    Gropper L; Gruenstein M; Shimkin MB
    Cancer Res; 1967 Nov; 27(11 Pt 2):1289-97. PubMed ID: 6073513
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs and their abuse no. V--misuse of cytotoxic drugs.
    Fennelly JJ
    J Ir Med Assoc; 1971 Jul; 64(416):383-4. PubMed ID: 5556314
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of head and neck cancer with intra-arterial cytotoxic drugs and radiotherapy.
    Sealy R; Helman P
    Cancer; 1972 Jul; 30(1):187-9. PubMed ID: 4625192
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy with L-asparaginase (EC-2) using P1798 lymphosarcoma.
    Mashburn LT
    Cancer; 1971 Nov; 28(5):1321-8. PubMed ID: 5001544
    [No Abstract]   [Full Text] [Related]  

  • 15. The prognosis and management of recurrent abdominal malignancies.
    Griffen WO; Humphrey L; Sosin H
    Curr Probl Surg; 1969 Apr; ():3-41. PubMed ID: 4183076
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormonal treatment of mammary tumors in rats induced by 3-methylcholanthrene (NSC-21970) and 7,12-dimethylbenz(alpha)anthracene (NSC-408823).
    Shimkin MB; Gropper L; Thatcher D; Gruenstein M
    Cancer Res; 1967 Nov; 27(11 Pt 2):1284-8. PubMed ID: 5630409
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement and inhibition of mammary tumor formation and growth by cytostatic drugs.
    Medina D; Shepherd F
    Cancer Res; 1977 Oct; 37(10):3571-7. PubMed ID: 908008
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intermittent polychemotherapy in inoperable bronchial cancer].
    Sighart H; Wrbka E; Simml G
    Wien Med Wochenschr; 1972 Aug; 122(33):485-9. PubMed ID: 4115554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.